Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD

Respiratory Medicine

Volumn 102, Issue 11, 2008, Pages 1654-1658

  Sitkauskiene, Brigita ^a   Serapinas, Danielius ^a   Blanco, Ignacio ^b   Fernández Bustillo, Enrique ^c   Janciauskiene, Sabina ^d   Sakalauskas, Raimundas ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b HOSPITAL VALLE DEL NALÓN   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Alpha1 antitrypsin deficiency; Chronic obstructive pulmonary disease; Population studies; Screening

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENOTYPE; HEALTH PROGRAM; HUMAN; ISOELECTRIC FOCUSING; LITHUANIA; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OUTPATIENT DEPARTMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SCREENING;

AGED; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; COHORT STUDIES; FEMALE; GENE FREQUENCY; HUMANS; LITHUANIA; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPIROMETRY;

EID: 55549147885     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.07.003     Document Type: Article

References (17)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD, executive Summary. 2006. [accessed 08.07].
2. American Thoracic Society/European Respiratory Society Statement: standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 168 (2003) 818-900
3. *Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J 27 (2006) 77-84
4. De Serres F.J., Blanco I., and Fernandez-Bustillo E. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening. COPD 3 (2006) 133-139
5. Gershagen S., and Janciauskiene S. ELISA for specific detection of PiZ-related alpha1-antitrypsin deficiency. Clin Chem 50 (2004) 2407-2410
6. Pierce J.A., and Eradio B.G. Improved identification of antitrypsin phenotypes through isoelectric focusing with dithioerythritol. J Lab Clin Med 94 (1979) 826-831
7. Beckman L., Sikström C., Mikelsaar A., Krumina A., Kucinskas V., and Beckman G. Alpha1-antitrypsin PI alleles as markers of West European influence in the Baltic Sea region. Hum Hered 49 (1999) 52-55
8. Stakisaitis D., Basys V., and Benetis R. Does alpha-1 proteinase inhibitor play a protective role in coronary atherosclerosis?. Med Sci Monit 7 (2001) 701-711
9. Lithuania S. http://www.stat.gov.lt/en/ [accessed 08.07]
10. Grabauskas V., Klumbiene J., Petkeviciene J., Kinderyte G., Sackute A., Hellasoja V., et al. Health behaviour among Lithuanian adult population. Available from: (2002), Publication of National Public Health Institute. https://www.ktl.fi/attachments/lithuania_finbaltreport2002.pdf B12/2003
11. De la Roza C., Rodríguez-Frías F., Lara B., Vidal R., Jardí R., and Miravitlles M. Results of a case-detection programme for alpha1-antitrypsin deficiency in COPD patients. Eur Respir J 26 (2005) 616-622
12. Luisetti M., Massi G., Massobrio M., Guarraci P., Menchicchi F.M., Beccaria M., et al. A national program for detection of alpha-1 antitrypsin deficiency in Italy. Respir Med 93 (1999) 169-172
13. Wencker M., Marx A., Konietzko N., Schaefer B., and Campbell E.J. Screening for alpha Pi deficiency in patients with lung diseases. Eur Respir J 20 (2002) 319-324
14. Bals R., Koczulla R., Kotke V., Andress J., Blackert K., and Vogelmeier C. Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program. Respir Med 101 (2007) 1708-1714
15. Dahl M., Tybjaerg-Hansen A., Lange P., Vestbo J., and Nordestgaard B.G. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 136 (2002) 270-279
16. *Z Alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Monaldi Arch Chest Dis 67 (2007) 184-208
17. Lindberg A., Jonsson A.C., Ronmark E., Lundgren R., Larsson L.G., and Lundback B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration 72 (2005) 471-479